257 related articles for article (PubMed ID: 9605421)
1. Suppression of inflammatory responses by surfactin, a selective inhibitor of platelet cytosolic phospholipase A2.
Kim K; Jung SY; Lee DK; Jung JK; Park JK; Kim DK; Lee CH
Biochem Pharmacol; 1998 Apr; 55(7):975-85. PubMed ID: 9605421
[TBL] [Abstract][Full Text] [Related]
2. Suppression of inflammatory responses to 12-O-tetradecanoyl-phorbol-13-acetate and carrageenin by YM-26734, a selective inhibitor of extracellular group II phospholipase A2.
Miyake A; Yamamoto H; Kubota E; Hamaguchi K; Kouda A; Honda K; Kawashima H
Br J Pharmacol; 1993 Sep; 110(1):447-53. PubMed ID: 8220906
[TBL] [Abstract][Full Text] [Related]
3. Purification of a 100 kDa phospholipase A2 from spleen, lung and kidney: antiserum raised to pig spleen phospholipase A2 recognizes a similar form in bovine lung, kidney and platelets, and immunoprecipitates phospholipase A2 activity.
Kim DK; Bonventre JV
Biochem J; 1993 Aug; 294 ( Pt 1)(Pt 1):261-70. PubMed ID: 8363579
[TBL] [Abstract][Full Text] [Related]
4. The novel natural product YM-26567-1 [(+)-trans-4-(3-dodecanoyl-2,4,6- trihydroxyphenyl)-7-hydroxy-2-(4-hydroxyphenyl)chroman]: a competitive inhibitor of group II phospholipase A2.
Miyake A; Yamamoto H; Takebayashi Y; Imai H; Honda K
J Pharmacol Exp Ther; 1992 Dec; 263(3):1302-7. PubMed ID: 1469636
[TBL] [Abstract][Full Text] [Related]
5. Variabilin: a dual inhibitor of human secretory and cytosolic phospholipase A2 with anti-inflammatory activity.
Escrig V; Ubeda A; Ferrandiz ML; Darias J; Sanchez JM; Alcaraz MJ; Paya M
J Pharmacol Exp Ther; 1997 Jul; 282(1):123-31. PubMed ID: 9223548
[TBL] [Abstract][Full Text] [Related]
6. Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation.
Marshall LA; Winkler JD; Griswold DE; Bolognese B; Roshak A; Sung CM; Webb EF; Jacobs R
J Pharmacol Exp Ther; 1994 Feb; 268(2):709-17. PubMed ID: 8113982
[TBL] [Abstract][Full Text] [Related]
7. Cytosolic phospholipase A2-mediated regulation of phospholipase D2 in leukocyte cell lines.
Kim JH; Lee BD; Kim Y; Lee SD; Suh PG; Ryu SH
J Immunol; 1999 Nov; 163(10):5462-70. PubMed ID: 10553072
[TBL] [Abstract][Full Text] [Related]
8. Effects of petrosaspongiolide M, a novel phospholipase A2 inhibitor, on acute and chronic inflammation.
Garcia-Pastor P; Randazzo A; Gomez-Paloma L; Alcaraz MJ; Paya M
J Pharmacol Exp Ther; 1999 Apr; 289(1):166-72. PubMed ID: 10087000
[TBL] [Abstract][Full Text] [Related]
9. PX-52, A novel inhibitor of 14 kDa secretory and 85 kDa cytosolic phospholipases A2.
Franson RC; Rosenthal MD
Adv Exp Med Biol; 1997; 400A():365-73. PubMed ID: 9547578
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of cytosolic phospholipase A2 as mediator of the enhanced arachidonic acid release from dimethyl sulphoxide differentiated U937 cells.
Withnall MT; Pennington A; Wiseman D
Biochem Pharmacol; 1995 Nov; 50(11):1893-902. PubMed ID: 8615870
[TBL] [Abstract][Full Text] [Related]
11. Evidence that 85 kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet-activating factor in human monocytes.
Winkler JD; Bolognese BJ; Roshak AK; Sung CM; Marshall LA
Biochim Biophys Acta; 1997 Jun; 1346(2):173-84. PubMed ID: 9219900
[TBL] [Abstract][Full Text] [Related]
12. Arachidonyl trifluoromethyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets.
Riendeau D; Guay J; Weech PK; Laliberté F; Yergey J; Li C; Desmarais S; Perrier H; Liu S; Nicoll-Griffith D
J Biol Chem; 1994 Jun; 269(22):15619-24. PubMed ID: 8195210
[TBL] [Abstract][Full Text] [Related]
13. Regulation of arachidonic acid, eicosanoid, and phospholipase A2 levels in murine mast cells by recombinant stem cell factor.
Fonteh AN; Samet JM; Chilton FH
J Clin Invest; 1995 Sep; 96(3):1432-9. PubMed ID: 7544805
[TBL] [Abstract][Full Text] [Related]
14. Novel inhibitor of phospholipase A2 with topical anti-inflammatory activity.
Tramposch KM; Steiner SA; Stanley PL; Nettleton DO; Franson RC; Lewin AH; Carroll FI
Biochem Biophys Res Commun; 1992 Nov; 189(1):272-9. PubMed ID: 1449483
[TBL] [Abstract][Full Text] [Related]
15. 3-(3,5-Dimethyl-4-octadecanoylpyrrol-2-yl)propionic acids as inhibitors of 85 kDa cytosolic phospholipase A2.
Lehr M
Arch Pharm (Weinheim); 1996 Nov; 329(11):483-8. PubMed ID: 8997897
[TBL] [Abstract][Full Text] [Related]
16. SB 203347, an inhibitor of 14 kDa phospholipase A2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxin shock.
Marshall LA; Hall RH; Winkler JD; Badger A; Bolognese B; Roshak A; Flamberg PL; Sung CM; Chabot-Fletcher M; Adams JL
J Pharmacol Exp Ther; 1995 Sep; 274(3):1254-62. PubMed ID: 7562496
[TBL] [Abstract][Full Text] [Related]
17. Roles of PMN leucocytes, platelets and some mediators in rat hind-paw oedema induced by two phospholipase A2 enzymes from Trimeresurus mucrosquamatus venom.
Wang JP; Teng CM
J Pharm Pharmacol; 1992 Apr; 44(4):300-5. PubMed ID: 1355540
[TBL] [Abstract][Full Text] [Related]
18. Effects of marine 2-polyprenyl-1,4-hydroquinones on phospholipase A2 activity and some inflammatory responses.
Gil B; Sanz MJ; Terencio MC; De Giulio A; De Rosa S; Alcaraz MJ; Payá M
Eur J Pharmacol; 1995 Oct; 285(3):281-8. PubMed ID: 8575515
[TBL] [Abstract][Full Text] [Related]
19. Glutamate stably enhances the activity of two cytosolic forms of phospholipase A2 in brain cortical cultures.
Kim DK; Rordorf G; Nemenoff RA; Koroshetz WJ; Bonventre JV
Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):83-90. PubMed ID: 7646475
[TBL] [Abstract][Full Text] [Related]
20. Cytosolic phospholipase A2 (PLA2), but not secretory PLA2, potentiates hydrogen peroxide cytotoxicity in kidney epithelial cells.
Sapirstein A; Spech RA; Witzgall R; Bonventre JV
J Biol Chem; 1996 Aug; 271(35):21505-13. PubMed ID: 8702935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
